Portfolio Review

It has been a while since I actually commented on the performance of my portfolio and updated the blog with my stock holdings.

My favourite stock of CVS Health remains a significant portion of my portfolio although I have trimmed the position as the price has been rising.

 The share has been booming on the back of realised synergies on the Aetna acquisition. Furthermore, earnings have been revised up repeatedly.

The position is up 42% on average - this is an average because I have purchased more and sold shares over the course of this position.








Next up is Royal Dutch Shell which has been a major holding in my portfolio due to the dividend yield.

However, the share price has not performed well and is down 14% since I opened the position.

The downward share price is interesting because oil prices have gradually been ticking upwards. Therefore, I think there could be a significant increase in share price after earnings beats.








Bristol Myers Squibb remains a key member of my portfolio and with strong earnings and a nice dividend it will remain there.

Shares are up 27% since I opened the position.















Next up is AT&T, I have trimmed the position recently as the share price has moved within the target range.

However, due to the sizeable dividend it remains a key part of the portfolio. Excluding dividends the position is up 20%.










The insurance industry makes up 25% of my portfolio and includes primarily Aviva and Legal and General.

Aviva trades roughly flat compared to the average buying price in the portfolio. However, with the 7% dividend the position is doing ok.

Legal and General is a 1/5 the size of my Aviva position and is up 6%.












I've trimmed my position in JP Morgan Chase lately as the price of the shares has increased significantly over the last year. The position is up 19% excluding dividends.

Sticking with banking, my position in Deutsche Bank has definitely been one of the under-peformers.

The position is down 16%.









Genworth Financial has recently dropped a little bit and the position is not up as much as it was 2 months ago.

However, the position remains up 10%.










The worst performer in the portfolio is Invesco shares are down 19% on the back of the Burford Capital issues and other concerns over Neil Woodford's former firm

That being said, the position is recovering slightly and is off its lows. I will continue to hold due to the dividend. 












The relatively new additions to my portfolio include Macy's as there is a fantastic dividend yield which looks relatively secure for now. Similarly, I have purchased Macy's options with a strike price at $22 a share for 6 months down the line. I appreciate this is a bet on a turnaround but there is a clear asset play now.

The value of their New York flagship store at Herald Square is worth more than the market cap in land value. Therefore, even if the company liquidated tomorrow there would be an upside of 25%.

The position is currently down 6% on average.




My most recent addition is Imperial Brand. I know the world is becoming more ethical in its mindedness and tobacco consumption is supposed to be reducing. But the fact of the matter is that cigarette earnings are continuing to rise.

There is also a well covered dividend with a forward dividend yield of around 16%.

The share is up 0.2% so far.